An ACT-Based Supportive Intervention for Patients With Central Nervous System Tumors

What this Trial Is About

Researchers are evaluating a psychosocial support program called ASCENT designed for adults recently diagnosed with malignant brain tumors. The study aims to determine if this ACT-based intervention is practical to offer and helpful to patients, focusing on those within six months of diagnosis. The research includes refining the intervention with feedback from patients and stakeholders before conducting a pilot randomized controlled trial comparing ASCENT to usual care. Participants in the ASCENT group will receive an intervention manual and take part in six individual coaching sessions with a clinician, scheduled weekly or every two weeks. The comparison group will receive usual supportive care, including referrals to cancer center supportive services like social work when requested. Both groups will be asked to complete surveys at four points: baseline, 6 weeks, 12 weeks, and 16 weeks. During the study, participants will complete short surveys to assess satisfaction, coping skills, psychological distress, and quality of life. Some may also provide feedback through interviews to help improve the intervention. Researchers will monitor enrollment rates, intervention participation, and satisfaction over up to 12 weeks, with exploratory measures extending to 16 weeks. The total study duration for each participant is approximately 16 weeks, with ongoing evaluations of psychological and behavioral outcomes.

ASCENT Intervention for Brain Tumor Patients